LENZ THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
LENZ THERAPEUTICS, INC. (LENZ) reported Basic Shares Outstanding (Weighted Average) of 31.37 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 31.37M shares, a 11.74% increase year-over-year.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 31.35M shares, a 13.90% increase year-over-year.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 31.10M shares, a 12.92% increase year-over-year.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 28.54M shares, a 5.04% increase year-over-year.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 28.81M shares, a 35.39% increase from fiscal 2024.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 21.28M shares, a 986.27% increase from fiscal 2023.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.96M shares, a 96.43% decline from fiscal 2022.
- LENZ THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 54.87M shares, a 89.75% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 31.37M shares 10-Q · filed 2026-08-11 | 31.36M shares 10-Q · filed 2026-08-11 | 31.27M shares derived: average of 3 quarters · filed 2026-08-11 | 30.59M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 31.35M shares 10-Q · filed 2026-05-11 | 31.22M shares derived: average of 2 quarters · filed 2026-05-11 | 30.33M shares derived: average of 3 quarters · filed 2026-05-11 | 29.77M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 31.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 29.82M shares derived: average of 2 quarters · filed 2026-03-24 | 29.24M shares derived: average of 3 quarters · filed 2026-08-11 | 28.81M shares 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | 28.54M shares 10-Q · filed 2025-11-05 | 28.31M shares derived: average of 2 quarters · filed 2026-08-11 | 28.05M shares 10-Q · filed 2025-11-05 | 27.92M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 28.08M shares 10-Q · filed 2026-08-11 | 27.80M shares 10-Q · filed 2026-08-11 | 27.71M shares derived: average of 3 quarters · filed 2026-08-11 | 27.58M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 27.53M shares 10-Q · filed 2026-05-11 | 27.53M shares derived: average of 2 quarters · filed 2026-05-11 | 27.41M shares derived: average of 3 quarters · filed 2026-05-11 | 26.96M shares derived: average of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | 27.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 27.36M shares derived: average of 2 quarters · filed 2026-03-24 | 26.77M shares derived: average of 3 quarters · filed 2026-03-24 | 21.28M shares 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | 27.17M shares 10-Q · filed 2025-11-05 | 26.39M shares derived: average of 2 quarters · filed 2025-11-05 | 19.20M shares 10-Q · filed 2025-11-05 | 14.87M shares derived: average of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | 25.61M shares 10-Q · filed 2025-07-30 | 15.16M shares 10-Q · filed 2025-07-30 | 10.76M shares derived: average of 3 quarters · filed 2025-07-30 | 8.56M shares derived: average of 4 quarters · filed 2025-07-30 | ||||
| 2024-03-31 | 4.72M shares 10-Q · filed 2025-05-07 | 3.34M shares derived: average of 2 quarters · filed 2025-05-07 | 2.88M shares derived: average of 3 quarters · filed 2025-05-07 | 2.65M shares derived: average of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | 1.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 1.96M shares derived: average of 2 quarters · filed 2025-03-19 | 1.96M shares derived: average of 3 quarters · filed 2025-03-19 | 1.96M shares 10-K · filed 2025-03-19 | 57.02M shares 10-K · filed 2024-02-27 | |||
| 2023-09-30 | 1.96M shares 10-Q · filed 2024-11-06 | 57.26M shares 10-Q · filed 2023-11-13 | 1.96M shares derived: average of 2 quarters · filed 2024-11-06 | 1.96M shares 10-Q · filed 2024-11-06 | 56.75M shares 10-Q · filed 2023-11-13 | 15.40M shares derived: average of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | 1.96M shares 10-Q · filed 2024-08-14 | 56.75M shares 10-Q · filed 2023-08-14 | 1.95M shares 10-Q · filed 2024-08-14 | 56.50M shares 10-Q · filed 2023-08-14 | 19.88M shares derived: average of 3 quarters · filed 2024-08-14 | 28.71M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 1.95M shares 10-Q · filed 2024-05-08 | 55.86M shares 10-Q · filed 2023-05-11 | 28.84M shares derived: average of 2 quarters · filed 2024-05-08 | 37.63M shares derived: average of 3 quarters · filed 2024-05-08 | 41.86M shares derived: average of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | 55.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 55.46M shares derived: average of 2 quarters · filed 2024-02-27 | 55.17M shares derived: average of 3 quarters · filed 2024-02-27 | 54.87M shares 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | 55.21M shares 10-Q · filed 2023-11-13 | 54.89M shares derived: average of 2 quarters · filed 2023-11-13 | 54.59M shares 10-Q · filed 2023-11-13 | 54.36M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 54.57M shares 10-Q · filed 2023-08-14 | 54.28M shares 10-Q · filed 2023-08-14 | 54.08M shares derived: average of 3 quarters · filed 2023-08-14 | 53.75M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 54.01M shares 10-Q · filed 2023-05-11 | 53.84M shares derived: average of 2 quarters · filed 2023-05-11 | 53.48M shares derived: average of 3 quarters · filed 2023-05-11 | 41.38M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 53.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 53.22M shares derived: average of 2 quarters · filed 2023-03-20 | 37.18M shares derived: average of 3 quarters · filed 2023-03-20 | 28.92M shares 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | 52.77M shares 10-Q · filed 2022-11-09 | 28.93M shares derived: average of 2 quarters · filed 2022-11-09 | 20.67M shares 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | 5.09M shares 10-Q · filed 2022-08-11 | 4.41M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |